QIAGEN powered by
Application Note: Developing a robust, automated, and streamlined clinical NGS workflow for hematological malignancies

QIAGEN Digital Insights Monday, July 6, 2020

Next-generation sequencing (NGS) has transformed the field of oncology. Early successes in identifying and targeting oncogenic drivers of solid tumors…

End of Life Notice: Ingenuity Variant Analysis (IVA)

QIAGEN Digital Insights Wednesday, April 15, 2020

In order to provide the best software and product support for our customers, QIAGEN must periodically retire older versions of…

HGMD 2020.1 Release

QIAGEN Digital Insights Tuesday, March 31, 2020

The Spring 2020 Release of the Human Gene Mutation Database (HGMD) Professional is available, expanding the world’s largest collection of…

LIVE WEBINAR: Closing the Precision Medicine Gap Using Whole Exome Sequencing

QIAGEN Digital Insights Monday, February 24, 2020

Wednesday, March 25, hear from Dr. Anthony M Magliocco, CEO and Founder of Protean BioDiagnostics, as he discusses the application…

QIAGEN CLC new release

QIAGEN Digital Insights Sunday, November 10, 2019

Check out some of the many new features delivered in the QIAGEN CLC solutions QIAGEN CLC Genomics Workbench 20.0: A…

QIAGEN wins at the 2nd annual Neurofibromatosis Hackathon

QIAGEN Digital Insights Tuesday, September 17, 2019

  Neurofibromatosis (NF) is a genetic disorder that causes tumors to form on nerve tissue. These tumors can develop anywhere…

Progranulin: A novel and sensitive biomarker with a key role in immune response in sepsis

QIAGEN Digital Insights Wednesday, September 11, 2019

QIAGEN collaborates with a team from the University of Munich by applying bioinformatics software tools OmicSoft ArrayStudio and Ingenuity Pathway Analysis (IPA) to discover progranulin as a novel and sensitive biomarker for sepsis.

Using liquid biopsy to guide clinical trial enrollment for patients with cancer

QIAGEN Digital Insights Monday, July 8, 2019

Investigators in the UK are using QIAGEN Clinical Insight (QCI) to identify clinically actionable mutations from blood-based sequencing results On…

Lab performing expanded carrier screening boosts efficiency by 80%

QIAGEN Digital Insights Saturday, June 1, 2019

A high-throughput population screening laboratory sees significant scale-up with implementation of QIAGEN Clinical Insight (QCI®) INTRODUCTION Genetic disease is the leading…

Structural Variant Detection using CLC Genomics Workbench

Thomas Poulsen Tuesday, March 19, 2019

Introduction to the Advanced Structural Variant Detection plugin for the CLC Genomics Workbench Structural variants affect large regions of the…

Find New Genomic Insights into Antimicrobial Resistance

Winnie Ridderberg Tuesday, February 5, 2019

Find resistance through surveillance and source tracing with two new tools: PointFinder and ShortBRED Winnie Ridderberg, PhD, Senior Scientist, Microbial…

Driving real-world impact with N-of-One, now a QIAGEN company

QIAGEN Digital Insights Wednesday, January 30, 2019

QIAGEN acquires N-of-One, expanding its clinical bioinformatics capabilities in molecular oncology decision support We are excited to announce our acquisition N-of-One,…

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.